Medicine passport

Pristiq Extended-Release 50 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Desvenlafaxine Succinate
Strength
50 mg
Form
Tablet, Extended Release
ATC code
Not stated by the register
Registered in
United States · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Prescription
Prescription only
NDC
0008-1211

Source: NDC Directory · 2026-09-13

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Canada 5 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
DESVENLAFAXINE50 mg · tablet (extended-release)Prescription onlySanis Health Inc (+2)02535106
APO-DESVENLAFAXINE50 mg · tablet (extended-release)Prescription onlyApotex Inc02466988
SANDOZ DESVENLAFAXINE50 mg · tablet (extended-release)Prescription onlySandoz Canada Incorporated02538415

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-13. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/us/en/medicines/pristiq-extended-release-50-mg-tablet-extended-release